The top-performing pharma and biotech stocks as group sees resurgence
Source: SeekingAlpha
2026-02-13 14:01:58 ET
More on pharmaceuticals, biotech
- Big Pharma's Earnings Week: Strong Performance, Obesity Wars, LOE Management And More
- BBH: Mature Biotech Exposure, But Limited Growth Ahead
- XPH: Healthcare Dashboard For January
- Most and least shorted mid-to mega-cap healthcare stocks in January
- FDA opens fast-track program to speed U.S. drug plant construction
Read the full article on Seeking Alpha
For further details see:
The top-performing pharma and biotech stocks as group sees resurgence
Cellectis S.A.
NASDAQ: CLLS
CLLS Trading
1.97% G/L:
$3.63 Last:
112,527 Volume:
$3.59 Open:
CLLS Latest News
December 15, 2025 05:39:45 pm
Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis
December 08, 2025 01:30:00 am
ASH 2025: Cellectis Presents Development Plan to Further Enhance High Response Rate Observed for Eti-cel in r/r NHL
CLLS Stock Data
$283,328,921
39,774,190
N/A
15
N/A
Biotechnology & Life Sciences
Healthcare
FR
Paris
